Skip to content
healthcare.dev

WEZLANA

NDC 84612-076, ustekinumab-auub, injection, solution, from Nuvaila Limited.

Product NDC
84612-076
Status
Listed
Labeler
Nuvaila Limited
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761285
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84612-076 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • USTEKINUMAB45 mg/.5mL

Pharmacologic classes

Interleukin-12 Antagonist [EPC]; Interleukin-12 Antagonists [MoA]; Interleukin-23 Antagonist [EPC]; Interleukin-23 Antagonists [MoA]

Package NDCNDC-11Package
84612-076-01846120076011 SYRINGE in 1 CARTON (84612-076-01) / .5 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a6c23978-09f0-4796-88f7-d0ce7e3ed04e

Use it

Look up 84612-076 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84612-076 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84612-076. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.